[O:1]=[C:2]1[CH2:8][CH:7]2[CH:9]([C:10](O)=O)[CH:4]([CH2:5][CH2:6]2)[CH2:3]1.Cl.[NH2:14][C:15]1[NH:20][C:19](=[O:21])[NH:18][C:17](=[O:22])[C:16]=1[NH2:23].CCN(C(C)C)[CH:27]([CH3:29])[CH3:28].[OH-].[K+].[CH3:35][CH:36](O)[CH3:37]>C(Cl)Cl.C(Cl)CCl>[O:1]=[C:2]1[CH2:3][CH:4]2[CH:9]([C:10]3[NH:23][C:16]4[C:17](=[O:22])[N:18]([CH2:28][CH2:27][CH3:29])[C:19](=[O:21])[N:20]([CH2:35][CH2:36][CH3:37])[C:15]=4[N:14]=3)[CH:7]([CH2:6][CH2:5]2)[CH2:8]13-Oxo-bicyclo[3.2.1]octane-8-carboxylic acid (205 mg) from step 1 was coupled to diaminouracil HCl (395 mg) using EDC (287 mg) in CH2Cl2 in the presence of DIEA (490 mg) and cyclized in iPrOH (50 ml), 1N KOH (10 ml) at reflux overnight. The crude product was purified on silica column. Yield (210 mg). Mass (ES+ 359).